The latest update is out from Sino Biopharmaceutical ( (HK:1177) ).
Sino Biopharmaceutical Limited has announced a final ordinary cash dividend of HKD 0.04 per share for the financial year ending December 31, 2024. The dividend, subject to shareholder approval on June 10, 2025, will be paid on July 10, 2025, with the ex-dividend date set for June 16, 2025. This announcement reflects the company’s financial performance and commitment to delivering shareholder value, potentially impacting investor sentiment and market positioning.
More about Sino Biopharmaceutical
Sino Biopharmaceutical Limited operates in the biopharmaceutical industry, focusing on the development, production, and distribution of a wide range of pharmaceutical products. The company is primarily engaged in the healthcare sector, providing innovative medicines and therapies to address various medical needs.
YTD Price Performance: 19.74%
Average Trading Volume: 1,083
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $8.69B
Learn more about 1177 stock on TipRanks’ Stock Analysis page.